Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Gel in Knee Osteoarthritis
NCT00171678Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Diclofenac Sodium Gel 1% with Vehicle Gel (2 arms). Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index Pain Subscale at 12 weeks, Western Ontario and McMaster Universities Osteoarthritis Index Physical Function Subscale at 12 weeks and 1 more. Started Oct 2004; status: completed.
02
Drugs
diclofenac sodium
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00171678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171678.